Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.69M | 8.59M | 19.24M | 18.91M | 20.85M | 21.89M | Gross Profit |
9.60M | 8.59M | 19.16M | 18.83M | 20.77M | 21.82M | EBIT |
1.97M | 1.39M | -27.73M | 12.07M | 32.24M | 14.94M | EBITDA |
28.45M | 1.34M | 7.13M | -10.54M | -1.84M | -2.79M | Net Income Common Stockholders |
-29.54M | -49.75M | -36.23M | 13.48M | -3.67M | -89.31M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
131.65M | 185.95M | 193.52M | 193.18M | 196.72M | 84.20M | Total Assets |
1.08B | 1.10B | 1.17B | 1.22B | 1.22B | 1.22B | Total Debt |
0.00 | 16.30M | 17.11M | 17.92M | 18.73M | 19.54M | Net Debt |
-131.65M | -124.31M | -117.15M | -102.72M | -89.56M | -8.44M | Total Liabilities |
9.71M | 22.72M | 22.99M | 23.85M | 27.76M | 26.63M | Stockholders Equity |
1.07B | 1.08B | 1.14B | 1.19B | 1.19B | 1.19B |
Cash Flow | Free Cash Flow | ||||
10.45M | 10.75M | 18.20M | 1.12M | 100.07M | -84.92M | Operating Cash Flow |
10.47M | 10.76M | 18.26M | 1.12M | 100.08M | -84.92M | Investing Cash Flow |
1.20M | 2.60M | 2.23M | 17.89M | -5.73M | -397.97M | Financing Cash Flow |
-22.71M | -7.02M | -6.86M | -6.67M | -14.04M | -7.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $76.04B | 20.00 | 2.17% | 1.81% | -30.38% | -43.73% | |
61 Neutral | $2.83B | 10.87 | 0.41% | 8.09% | 5.96% | -21.24% | |
60 Neutral | HK$1.71B | ― | -0.17% | 6.99% | -37.82% | -104.07% | |
52 Neutral | $5.53B | 28.28 | 0.47% | 5.22% | -18.65% | -78.51% | |
43 Neutral | HK$150.00M | ― | -2.72% | 2.13% | 16.45% | 21.04% | |
42 Neutral | HK$1.18B | ― | -3.47% | 8.14% | 7.83% | -296.70% | |
35 Underperform | HK$1.42B | ― | -25.08% | ― | -39.64% | -125.38% |